Article
Report on stage III Pig-a mutation assays using benzo[a]pyrene.
Environmental and molecular mutagenesis - 1 Dec 2011
Bhalli Javed A, Shaddock Joseph G, Pearce Mason G, Dobrovolsky Vasily N, Cao Xuefei, Heflich Robert H, Vohr Hans-Werner
Abstract excerpt
Genotoxicity assays were conducted on rats treated with benzo[a]pyrene (BaP) as part of Stage III of a validation study on the Pig-a gene mutation assay. Assays were performed at the U.S. FDA-NCTR and Bayer-Germany. Starting on Day 1, groups of five 6- to 7-week-old male Fischer 344 (F344, used at FDA-NCTR) and Han Wistar rats (Bayer) were given 28 daily doses of 0, 37.5, 75, or 150 mg/kg BaP; blood was sampled...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
